Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Rylo | 2026 | Venture - Series Unknown | $11.0M | New York |
| IDEAYA Biosciences | 2026 | Post-IPO Equity | Undisclosed | South San Francisco |
| Aeva | 2026 | Post-IPO Equity | Undisclosed | Mountain View |
| Vedana Therapeutics | 2026 | Series A | Undisclosed | Seattle |
| AttoTude | 2026 | Series C | $50.0M | Menlo Park |
| Tomorrow.io | 2026 | Series F | Undisclosed | Boston |
| Hermeus | 2026 | Series C | $40.0M | El Segundo |
| C-Infinity | 2026 | Seed | Undisclosed | Mountain View |
| Transposon Therapeutics | 2026 | Grant | $22.0M | Westport |
| Vima Therapeutics | 2026 | Series A | $40.0M | Cambridge |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Rylo | Venture - Series Unknown | $11.0M | New York, United States |
| 2 | IDEAYA Biosciences | Post-IPO Equity | Undisclosed | South San Francisco, United States |
| 3 | Aeva | Post-IPO Equity | Undisclosed | Mountain View, United States |
| 4 | Vedana Therapeutics | Series A | Undisclosed | Seattle, United States |
| 5 | AttoTude | Series C | $50.0M | Menlo Park, United States |
| 6 | Tomorrow.io | Series F | Undisclosed | Boston, United States |
| 7 | Hermeus | Series C | $40.0M | El Segundo, United States |
| 8 | C-Infinity | Seed | Undisclosed | Mountain View, United States |
| 9 | Transposon Therapeutics | Grant | $22.0M | Westport, United States |
| 10 | Vima Therapeutics | Series A | $40.0M | Cambridge, United States |
Rylo is building the future of communication with AI-powered tools that empower deaf and hard-of-hearing people to communicate.
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
Aeva develops a sensing and perception paradigm for autonomous machines.
Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
AttoTude develops interconnect technology for artificial intelligence and hyperscale data center environments.
Tomorrow.io is a weather technology company offering real-time forecasting services to predict and respond to climate-related threats.
Hermeus is a defense aviation company that designs, builds, and tests high-Mach and hypersonic aircraft.
C-Infinity develops AI software for data processing and automation for mechanical design and manufacturing.
Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
Vima Therapeutics operates as a biotechnology company.
Journey Live offers a preventative mental health solution to reduce turnover, tackle burnout, and help employees live healthier lives.
Gemist is the first-ever D2C custom jewelry company that allows consumers to design jewelry and try it on before they buy.
Actio Biosciences is a research center that develops drugs for rare diseases.
UrbanSitter is an online hub connecting families with babysitters through social networks.
Cynomi provides an AI platform for automating risk assessments and compliance.
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
WiseLayer makes AI-powered digital workers for finance and accounting teams.
Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.
RenoFi helps homeowners discover a smart way to finance their renovation and tackle everything on their wishlist.
Enterpret analyzes customer feedback using AI and NLP, offering tailored insights for product growth.
Nivoda is a digital marketplace and supply chain for natural and lab-grown diamonds.
Treehouse is a software-enabled service for home electrification.
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
Canaan Partners has invested in 172 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Canaan Partners's top investment sectors include Biotechnology, Health Care, Medical, Artificial Intelligence (AI), Therapeutics. The firm invests across 58 different industry categories.
Among tracked funding rounds, Genome Medical received $75.3M in a Venture - Series Unknown round. Canaan Partners's total known invested capital is $3.1B.
Canaan Partners's average investment size is $26.7M across its portfolio of 172 companies.
Recent Canaan Partners portfolio additions include Rylo, IDEAYA Biosciences, Aeva, Vedana Therapeutics, AttoTude. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors